Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Cottin

Showing results (371-380 of 468) with videos related to

Pageof 47
Sort By:
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
Autoimmunity Reviews|September 28, 2016
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
Medicine|August 29, 2013
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 CasesFanny Legrand, Aline Renneville, Elizabeth MacIntyre, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
Respirology (Carlton, Vic.)|January 4, 2022
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective studyQuentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, et al.
The European Respiratory Journal|February 6, 2025
Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networksRomy Ratsihorimanana, Thomas Maitre, Matthieu Dusselier, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2017
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice GuidelineNishant Gupta, Geraldine A Finlay, Robert M Kotloff, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2014
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelinesVincent Cottin, Bruno Crestani, Dominique Valeyre, et al.
Pageof 47

Showing results (371-380 of 468) with videos related to

Sort By:
Pageof 47
Thorax|October 16, 2019
Risk factors for disease progression in idiopathic pulmonary fibrosisGanesh Raghu, Brett Ley, Kevin K Brown, et al.
Autoimmunity Reviews|September 28, 2016
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
Medicine|August 29, 2013
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 CasesFanny Legrand, Aline Renneville, Elizabeth MacIntyre, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
The New England Journal of Medicine|May 20, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosisLuca Richeldi, Roland M du Bois, Ganesh Raghu, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
Respirology (Carlton, Vic.)|January 4, 2022
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: A multicentre retrospective studyQuentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, et al.
The European Respiratory Journal|February 6, 2025
Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networksRomy Ratsihorimanana, Thomas Maitre, Matthieu Dusselier, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2017
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice GuidelineNishant Gupta, Geraldine A Finlay, Robert M Kotloff, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2014
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelinesVincent Cottin, Bruno Crestani, Dominique Valeyre, et al.
Pageof 47